Trafalgar International TRFA
OTC TRFA
$0.75 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Trafalgar International (TRFA) Return on Equity [ROE] (2018)

Updated

Trafalgar International's Return on Equity [ROE] came in at 47.33% for Q2 2018.

Analysis

Trafalgar International (TRFA) Return on Equity [ROE] (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 19.33%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 5.63%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 29.03%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 17.57%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 72.13%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -31.17%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 4.66%
10 Trafalgar International 708,701.25 658,380.25 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 47.33%
API Access

Trafalgar International Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TRFA&period=max&api_key=YOUR_API_KEY